Profiel
Dr. David M.
Gravett is Vice President-Research & Development at Carbylan Therapeutics, Inc.
Dr. Gravett was previously employed as Vice President-Formulations & Polymer Chemistry by Angiotech Pharmaceuticals, Inc. and a Principal by Pasteur Mérieux Connaught.
He received his doctorate degree from the University of Toronto.
Eerdere bekende functies van David M. Gravett
| Bedrijven | Functie | Einde |
|---|---|---|
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Hoofd Techniek/Wetenschap/O&O | 15-04-2016 |
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Corporate Officer/Principal | - |
Pasteur Mérieux Connaught | Corporate Officer/Principal | - |
Opleiding van David M. Gravett
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
University of Natal
University of Natal Other Consumer ServicesConsumer Services College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pasteur Mérieux Connaught |
















